Psychedelic Group Therapy.
Current Topics in Behavioral Neurosciences 2022 DOI: 10.1007/7854_2021_268 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Group psychotherapy Group therapy Psychedelics assisted therapy |
| Key points | Argues that while individual therapy with one or two therapists has been the most common model in psychedelic clinical research and treatment, group psychedelic treatment has been conducted in specific settings in Switzerland since the founding of the Swiss Medical Society for Psycholytic Therapy (SÄPT) in 1985, and describes this approach. |
Abstract
Gatherings in groups are a ubiquitous phenomenon throughout human history. This is true for everyday social tasks as well as for healing and spiritual purposes. In psychotherapy, group treatment started soon after developing psychoanalytic treatment procedures. For psychedelic therapy however, individual treatment guided by one or sometimes even two therapists is the most common and widespread treatment model for clinical research and therapy thus far. Since the foundation of the Swiss Medical Society for Psycholytic Therapy (Schweizerische Ärztegesellschaft für psycholytische Therapie, SÄPT) in 1985 in Switzerland, we however had the opportunity to conduct psychedelic group treatment in specific settings, which the following article describes.
Citations in the library
Cited by 18
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Treatment with psychedelics is psychotherapy: beyond reductionism The Lancet Psychiatry December 12, 2023
- Lower-dose psycholytic therapy – A neglected approach Frontiers in Psychiatry December 2, 2022
- Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders Frontiers in Psychiatry April 25, 2022
- Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism. Neuropsychopharmacology July 21, 2023
and 13 more in the library
Cites 4
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Journal of Psychopharmacology October 31, 2012
- Psychedelic-Assisted Group Therapy: A Systematic Review Journal of Psychoactive Drugs March 15, 2019
- Acute subjective effects in LSD- and MDMA-assisted psychotherapy Journal of Psychopharmacology October 8, 2020